Matches in Harvard for { <http://id.lib.harvard.edu/aleph/008053389/catalog> ?p ?o. }
Showing items 1 to 31 of
31
with 100 items per page.
- catalog contributor b11182146.
- catalog contributor b11182147.
- catalog contributor b11182148.
- catalog created "c1999.".
- catalog date "1999".
- catalog date "c1999.".
- catalog dateCopyrighted "c1999.".
- catalog description "Includes bibliographical references and index.".
- catalog description "Overview of regulatory expectations for introducing novel therapies into clinical trials -- Preparation of clinical trial supplies of biopharmaceuticals -- Proteins as drugs: analysis, formulation and delivery -- Strategies for dealing with the immunogenicity of therapeutic proteins -- Targeted toxin hybrid proteins -- SB209763: a humanized monoclonal antibody for the prophylaxis and treatment of respiratory syncytial virus infection -- Preclinical development of antisense therapeutics -- Formulation and delivery of nucleic acids -- Safe, efficient production of retroviral vectors -- Clinical systems for the production of cells and tissues for human therapy -- Subject index.".
- catalog extent "xvii, 248 p. :".
- catalog hasFormat "Novel therapeutics from modern biotechnology.".
- catalog identifier "3540650253 (hardcover : alk. paper)".
- catalog isFormatOf "Novel therapeutics from modern biotechnology.".
- catalog isPartOf "Handbook of experimental pharmacology ; v. 137".
- catalog issued "1999".
- catalog issued "c1999.".
- catalog language "eng".
- catalog publisher "Berlin ; New York : Springer,".
- catalog relation "Novel therapeutics from modern biotechnology.".
- catalog subject "615/.1 s 615/.19 21".
- catalog subject "Biotechnology.".
- catalog subject "Drug Design.".
- catalog subject "Drug Evaluation.".
- catalog subject "Pharmaceutical biotechnology.".
- catalog subject "QP905 .H3 vol. 137 RS380".
- catalog subject "QV 744 N937 1999".
- catalog subject "Technology, Pharmaceutical.".
- catalog subject "W1 HA51L v.137 1999".
- catalog tableOfContents "Overview of regulatory expectations for introducing novel therapies into clinical trials -- Preparation of clinical trial supplies of biopharmaceuticals -- Proteins as drugs: analysis, formulation and delivery -- Strategies for dealing with the immunogenicity of therapeutic proteins -- Targeted toxin hybrid proteins -- SB209763: a humanized monoclonal antibody for the prophylaxis and treatment of respiratory syncytial virus infection -- Preclinical development of antisense therapeutics -- Formulation and delivery of nucleic acids -- Safe, efficient production of retroviral vectors -- Clinical systems for the production of cells and tissues for human therapy -- Subject index.".
- catalog title "Novel therapeutics from modern biotechnology : from laboratory to human testing / contributors, A. Abuchowski ... [et al.] ; editors, Dale L. Oxender and Leonard E. Post.".
- catalog type "text".